Burkitt's lymphoma shortly after an acute HIV infection, treated with highly active retroviral treatment

Acta Clinica Belgica

Volumn 56, Issue 5, 2001, Pages 321-322

  Colebunders, R ^a   Dohmen, S ^a   Van de Velde, A ^a   Pelgrom, J ^a   Hermans, P ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; DIDANOSINE; DOXORUBICIN; INDINAVIR; LAMIVUDINE; PREDNISONE; RITONAVIR; STAVUDINE; VINCRISTINE; ZIDOVUDINE;

ADULT; BURKITT LYMPHOMA; CASE REPORT; CENTRAL NERVOUS SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LETTER; LYMPHOCYTE COUNT; MALE; OPPORTUNISTIC INFECTION; VIRUS LOAD;

EID: 0035206193     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2001.047     Document Type: Letter

References (5)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. Impact of potent antiretroviral therapy on the incidence of Kaposi's Sarcoma and non-Hodgkin's lymphoma among HIV-1-infected individuals
3. Spectrum of AIDS-associated malignant disorders
4. Role of zidovudine antiretroviral therapy in the pathogenesis of AIDS-related lymphoma
5. Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses